Clinical Trial Update: A Phase II Study of the FIL on Elderly Frail Patients With DLBCL [Phase 2]

View source ↗

Summary

Phase II study update of FIL in elderly frail patients with Diffuse Large B-Cell Lymphoma (DLBCL) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• FIL

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Diffuse Large B-cells Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED